中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
首页
机构
成果
学者
登录
注册
登陆
×
验证码:
换一张
忘记密码?
记住我
×
校外用户登录
CAS IR Grid
机构
上海药物研究所 [6]
地质与地球物理研究所 [1]
数学与系统科学研究院 [1]
合肥物质科学研究院 [1]
采集方式
OAI收割 [9]
内容类型
期刊论文 [9]
发表日期
2024 [1]
2022 [4]
2021 [1]
2020 [2]
2019 [1]
学科主题
筛选
浏览/检索结果:
共9条,第1-9条
帮助
条数/页:
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100
排序方式:
请选择
题名升序
题名降序
提交时间升序
提交时间降序
作者升序
作者降序
发表日期升序
发表日期降序
Low-Dose Chemotherapy Preferentially Shapes the Ileal Microbiome and Augments the Response to Immune Checkpoint Blockade by Activating AIM2 Inflammasome in Ileal Epithelial Cells
期刊论文
OAI收割
ADVANCED SCIENCE, 2024, 页码: 17
作者:
Pu, Congying
;
Li, Yize
;
Fu, Yixian
;
Yan, Yiyang
;
Tao, Siyao
  |  
收藏
  |  
浏览/下载:43/0
  |  
提交时间:2024/02/27
AIM2 inflammasome
chemotherapy
gut microbiome
ileal epithelial cells
immune checkpoint blockade
lactobacillus
segmented filamentous bacterium
Biogenic platinum nanoparticles on bacterial fragments for enhanced radiotherapy to boost antitumor immunity
期刊论文
OAI收割
NANO TODAY, 2022, 卷号: 47, 页码: 10
作者:
Deng, Zheng
;
Liu, Jiawei
;
Xi, Min
;
Wang, Chunjie
;
Fang, Huapan
  |  
收藏
  |  
浏览/下载:10/0
  |  
提交时间:2023/12/29
Radiotherapy
Platinum nanoparticles
Shewanella oneidensis MR-1
Immune checkpoint blockade
Anti-tumor immunity
Lenvatinib- and vadimezan-loaded synthetic high-density lipoprotein for combinational immunochemotherapy of metastatic triple-negative breast cancer
期刊论文
OAI收割
ACTA PHARMACEUTICA SINICA B, 2022, 卷号: 12, 期号: 9, 页码: 3726-3738
作者:
Zheng, Chao
;
Zhang, Wen
;
Wang, Jinming
;
Zhai, Yihui
;
Xiong, Fengqin
  |  
收藏
  |  
浏览/下载:55/0
  |  
提交时间:2022/12/13
KEY WORDS High-density lipoprotein
Immunotherapy
Combination therapy
Metastasis
Triple-negative breast cancer
Lenvatinib
Vadimezan
Immune checkpoint blockade
Engineered nanomedicines block the PD-1/PD-L1 axis for potentiated cancer immunotherapy
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2022, 页码: 10
作者:
Li, Jun-hao
;
Huang, Lu-jia
;
Zhou, Hui-ling
;
Shan, Yi-ming
;
Chen, Fang-min
  |  
收藏
  |  
浏览/下载:32/0
  |  
提交时间:2022/08/16
cancer immunotherapy
immune checkpoint blockade
PD-1/PD-L1 axis
nanomedicine
nanosized drug delivery systems
hDirect-MAP: projection-free single-cell modeling of response to checkpoint immunotherapy
期刊论文
OAI收割
BRIEFINGS IN BIOINFORMATICS, 2022, 卷号: 23, 期号: 2, 页码: 16
作者:
Lu, Yong
;
Xue, Gang
;
Zheng, Ningbo
;
Han, Kun
;
Yang, Wenzhong
  |  
收藏
  |  
浏览/下载:31/0
  |  
提交时间:2023/02/07
single-cell RNA sequencing (scRNA-seq)
single-cell mass cytometry (CyTOF)
Pareto optimization
projection-free single-cell modeling
response to immune checkpoint blockade
Anti-PD-Ll mediating tumor-targeted codelivery of liposomal irinotecan/JQl for chemo-immunotherapy
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2021, 卷号: 42, 期号: 9, 页码: 1516
作者:
He Zhidi
;
Zhang Meng
;
Wang Yonghui
;
He Yang
;
Wang Hairui
  |  
收藏
  |  
浏览/下载:11/0
  |  
提交时间:2023/05/22
tumor-targeted delivery
immunogenic cell death
PD-1/PD-L1 blockade
tumor immune microenvironment
irinotecan
JQ1
immune checkpoint
Beyond Blocking: Engineering RNAi-Mediated Targeted Immune Checkpoint Nanoblocker Enables T-Cell-lndependent Cancer Treatment
期刊论文
OAI收割
ACS NANO, 2020, 卷号: 14
作者:
Han, Xiaoyan
;
Wang, Linlin
;
Li, Ting
;
Zhang, Jiahui
;
Zhang, Dailiang
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2021/03/15
immune checkpoint blockade
RNAi engineering
nanostructure
NSCLC
cancer immunotherapy
Anti-PD-L1 mediating tumor-targeted codelivery of liposomal irinotecan/JQ1 for chemo-immunotherapy
期刊论文
OAI收割
ACTA PHARMACOLOGICA SINICA, 2020, 页码: 8
作者:
He, Zhi-di
;
Zhang, Meng
;
Wang, Yong-hui
;
He, Yang
;
Wang, Hai-rui
  |  
收藏
  |  
浏览/下载:44/0
  |  
提交时间:2021/05/24
tumor-targeted delivery
immunogenic cell death
PD-1
PD-L1 blockade
tumor immune microenvironment
irinotecan
JQ1
immune checkpoint
Enhancing Triple Negative Breast Cancer Immunotherapy by ICG-Templated Self-Assembly of Paclitaxel Nanoparticles
期刊论文
OAI收割
ADVANCED FUNCTIONAL MATERIALS, 2019, 页码: 13
作者:
Feng, Bing
;
Niu, Zifei
;
Hou, Bo
;
Zhou, Lei
;
Li, Yaping
  |  
收藏
  |  
浏览/下载:34/0
  |  
提交时间:2020/07/01
immune checkpoint blockade
immunogenic cell death
immunotherapy
self-assemble
triple negative breast cancer